Colin Reisner
Biopharma Technology (United Kingdom)(GB)
Publications by Year
Research Areas
Inhalation and Respiratory Drug Delivery, Chronic Obstructive Pulmonary Disease (COPD) Research, Asthma and respiratory diseases, Respiratory and Cough-Related Research, Respiratory Support and Mechanisms
Most-Cited Works
- → Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD(2020)656 cited
- → The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation(2005)460 cited
- → Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial(2018)391 cited
- → The Efficacy and Safety of Fluticasone Propionate (250 μg)/Salmeterol (50 μg) Combined in the Diskus Inhaler for the Treatment of COPD(2003)327 cited
- → Uncontrolled asthma: A review of the prevalence, disease burden and options for treatment(2006)318 cited
- → Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study(2020)250 cited